Ocular toxoplasmosis: the treatment dilemma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of AAPOS 2013-10, Vol.17 (5), p.454-455
Hauptverfasser:	Schallhorn, Julie M., MD, MS, Gonzales, John, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiprotozoal Agents - adverse effects Chorioretinitis - drug therapy Drug Hypersensitivity - etiology Eosinophilia - chemically induced Female Humans Ophthalmology Toxoplasmosis, Ocular - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	455
container_issue	5
container_start_page	454
container_title	Journal of AAPOS
container_volume	17
creator	Schallhorn, Julie M., MD, MS Gonzales, John, MD
description
doi_str_mv	10.1016/j.jaapos.2013.08.001
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1446872894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1091853113002590</els_id><sourcerecordid>1446872894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-c549fe8985a9e31792b101cbf9e4dfbce8373e451c8c06ad79420e19e47c66e73</originalsourceid><addsrcrecordid>eNqFkU1P3DAQhi1UxMeWf1ChPVaqEmZiJ7F7qIRQS5GQOEDPlteZCKdJvNgJKv8er7Jw6IXTjDTvOx_PMPYFIUfA6qLLO2O2PuYFIM9B5gB4wE6wLGTGFeefUg4KM1lyPGanMXYAUCnEI3ZcCKxAVXjCvt3ZuTdhPfl_ftubOPjo4vf19EjrKZCZBhqndeN6GgbzmR22po90to8r9ufXz4er39nt3fXN1eVtZgXWU2ZLoVqSSpZGEcdaFZu0sN20ikTTbixJXnMSJVppoTJNrUQBhKla26qimq_Y16XvNvinmeKkBxct9b0Zyc9RoxCVrAupRJKKRWqDjzFQq7fBDSa8aAS9w6Q7vWDSO0wapE6Yku18P2HeDNS8m964JMGPRUDpzmdHQUfraLTUuEB20o13H034v4Ht3eis6f_SC8XOz2FMDDXqWGjQ97tX7T6FHKAoFfBXwl6OeA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1446872894</pqid></control><display><type>article</type><title>Ocular toxoplasmosis: the treatment dilemma</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Schallhorn, Julie M., MD, MS ; Gonzales, John, MD</creator><creatorcontrib>Schallhorn, Julie M., MD, MS ; Gonzales, John, MD</creatorcontrib><identifier>ISSN: 1091-8531</identifier><identifier>EISSN: 1528-3933</identifier><identifier>DOI: 10.1016/j.jaapos.2013.08.001</identifier><identifier>PMID: 24160961</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Antiprotozoal Agents - adverse effects ; Chorioretinitis - drug therapy ; Drug Hypersensitivity - etiology ; Eosinophilia - chemically induced ; Female ; Humans ; Ophthalmology ; Toxoplasmosis, Ocular - drug therapy</subject><ispartof>Journal of AAPOS, 2013-10, Vol.17 (5), p.454-455</ispartof><rights>American Association for Pediatric Ophthalmology and Strabismus</rights><rights>2013 American Association for Pediatric Ophthalmology and Strabismus</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-c549fe8985a9e31792b101cbf9e4dfbce8373e451c8c06ad79420e19e47c66e73</citedby><cites>FETCH-LOGICAL-c417t-c549fe8985a9e31792b101cbf9e4dfbce8373e451c8c06ad79420e19e47c66e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1091853113002590$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24160961$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schallhorn, Julie M., MD, MS</creatorcontrib><creatorcontrib>Gonzales, John, MD</creatorcontrib><title>Ocular toxoplasmosis: the treatment dilemma</title><title>Journal of AAPOS</title><addtitle>J AAPOS</addtitle><subject>Antiprotozoal Agents - adverse effects</subject><subject>Chorioretinitis - drug therapy</subject><subject>Drug Hypersensitivity - etiology</subject><subject>Eosinophilia - chemically induced</subject><subject>Female</subject><subject>Humans</subject><subject>Ophthalmology</subject><subject>Toxoplasmosis, Ocular - drug therapy</subject><issn>1091-8531</issn><issn>1528-3933</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1P3DAQhi1UxMeWf1ChPVaqEmZiJ7F7qIRQS5GQOEDPlteZCKdJvNgJKv8er7Jw6IXTjDTvOx_PMPYFIUfA6qLLO2O2PuYFIM9B5gB4wE6wLGTGFeefUg4KM1lyPGanMXYAUCnEI3ZcCKxAVXjCvt3ZuTdhPfl_ftubOPjo4vf19EjrKZCZBhqndeN6GgbzmR22po90to8r9ufXz4er39nt3fXN1eVtZgXWU2ZLoVqSSpZGEcdaFZu0sN20ikTTbixJXnMSJVppoTJNrUQBhKla26qimq_Y16XvNvinmeKkBxct9b0Zyc9RoxCVrAupRJKKRWqDjzFQq7fBDSa8aAS9w6Q7vWDSO0wapE6Yku18P2HeDNS8m964JMGPRUDpzmdHQUfraLTUuEB20o13H034v4Ht3eis6f_SC8XOz2FMDDXqWGjQ97tX7T6FHKAoFfBXwl6OeA</recordid><startdate>20131001</startdate><enddate>20131001</enddate><creator>Schallhorn, Julie M., MD, MS</creator><creator>Gonzales, John, MD</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131001</creationdate><title>Ocular toxoplasmosis: the treatment dilemma</title><author>Schallhorn, Julie M., MD, MS ; Gonzales, John, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-c549fe8985a9e31792b101cbf9e4dfbce8373e451c8c06ad79420e19e47c66e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antiprotozoal Agents - adverse effects</topic><topic>Chorioretinitis - drug therapy</topic><topic>Drug Hypersensitivity - etiology</topic><topic>Eosinophilia - chemically induced</topic><topic>Female</topic><topic>Humans</topic><topic>Ophthalmology</topic><topic>Toxoplasmosis, Ocular - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schallhorn, Julie M., MD, MS</creatorcontrib><creatorcontrib>Gonzales, John, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of AAPOS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schallhorn, Julie M., MD, MS</au><au>Gonzales, John, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ocular toxoplasmosis: the treatment dilemma</atitle><jtitle>Journal of AAPOS</jtitle><addtitle>J AAPOS</addtitle><date>2013-10-01</date><risdate>2013</risdate><volume>17</volume><issue>5</issue><spage>454</spage><epage>455</epage><pages>454-455</pages><issn>1091-8531</issn><eissn>1528-3933</eissn><cop>United States</cop><pub>Mosby, Inc</pub><pmid>24160961</pmid><doi>10.1016/j.jaapos.2013.08.001</doi><tpages>2</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 1091-8531
ispartof	Journal of AAPOS, 2013-10, Vol.17 (5), p.454-455
issn	1091-8531 1528-3933
language	eng
recordid	cdi_proquest_miscellaneous_1446872894
source	MEDLINE; Elsevier ScienceDirect Journals Complete
subjects	Antiprotozoal Agents - adverse effects Chorioretinitis - drug therapy Drug Hypersensitivity - etiology Eosinophilia - chemically induced Female Humans Ophthalmology Toxoplasmosis, Ocular - drug therapy
title	Ocular toxoplasmosis: the treatment dilemma
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T00%3A12%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ocular%20toxoplasmosis:%20the%20treatment%20dilemma&rft.jtitle=Journal%20of%20AAPOS&rft.au=Schallhorn,%20Julie%20M.,%20MD,%20MS&rft.date=2013-10-01&rft.volume=17&rft.issue=5&rft.spage=454&rft.epage=455&rft.pages=454-455&rft.issn=1091-8531&rft.eissn=1528-3933&rft_id=info:doi/10.1016/j.jaapos.2013.08.001&rft_dat=%3Cproquest_cross%3E1446872894%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1446872894&rft_id=info:pmid/24160961&rft_els_id=1_s2_0_S1091853113002590&rfr_iscdi=true